by Christina Arshadi | Sep 20, 2024 | Blog
Immunotherapies were back in the spotlight at the European Society for Medical Oncology’s congress this year, but its limitations are prompting a strategic realignment. Back in style Our analysis of last year’s ESMO congress discovered a notable focus on...
by Sofia Tzamarelou | Jul 23, 2024 | Blog
Pharma PR and comms need new strategies to reduce the stigma around lung cancer, which gets in the way of screening rates and drug development. Lung cancer has a branding problem More people die from lung cancer than any other cancer, and it kills more women than...
by Georgi Ivanov | Jun 10, 2024 | Blog
ASCO’s focus on less invasive treatment suggests a narrative shift in oncology: that doing less — less surgery, less chemotherapy or less radiation — can help patients live longer and feel better. The context: The 2024 edition of the American Society of Clinical...
by Commetric | Jan 3, 2024 | Blog
At Commetric, we’re in the habit of turning to data to answer any question. So, when we wanted to look at the most prominent PR trends in 2023, we decided to check which of our analyses received the most attention from our readers – who are predominantly...
by Commetric | Oct 30, 2023 | Blog
An estimated 33,000 people walked the halls of the European Society for Medical Oncology’s (ESMO) 2023 gathering. The event – which has a reputation for being the most influential oncology congress – is used by many pharma companies as a...
